CCMC-Na Supplier: High-Purity Sodium Carboxymethyl Cellulose | Order Now

The pharmaceutical industry is experiencing revolutionary transformations driven by novel excipient technologies. Among these innovations, Cross-linked sodium carboxymethyl cellulose (CCMC-Na) has emerged as a critical functional material for tablet formulation. This extensively modified cellulose derivative represents a significant advancement in superdisintegrant technology with unique properties that enhance drug delivery systems.

Technical Properties of CCMC-Na

CCMC-Na demonstrates superior performance characteristics compared to traditional disintegrants. Its unique physicochemical properties result from the controlled cross-linking of carboxymethyl cellulose chains, creating a polymer network that swells dramatically upon contact with aqueous fluids without dissolving. This section examines the technical specifications critical for pharmaceutical applications.

Material Specifications

Parameter	Test Method	Specification Range	Pharmaceutical Significance
Appearance	Visual Inspection	White to off-white powder	Indicates purity and processing quality
Substitution Degree (DS)	ASTM D1439	0.65 - 0.90	Determines hydrophilicity and swelling capacity
Cross-linking Density	SEC-MALLS Analysis	12-18%	Controls swelling kinetics and disintegration efficiency
Particle Size (D50)	Laser Diffraction	50-120 μm	Impacts flow properties and compressibility
Swelling Volume (pH 6.8)	USP 30 <701>	40-65 mL/g	Measure of disintegrant efficiency
Loss on Drying	USP <731>	<8.0%	Moisture content impacts stability and compressibility
pH (1% solution)	USP <791>	5.0 - 7.0	Critical for compatibility with API chemistry
Bulk Density	USP <616>	0.35 - 0.55 g/cm³	Determines blending uniformity and flow characteristics

Mechanism of Action

Cross-linked sodium carboxymethyl cellulose operates through three primary disintegration mechanisms: wicking (capillary action), swelling pressure generation, and disruption of particle-particle bonds. When CCMC-Na comes into contact with aqueous fluids, rapid water absorption occurs through capillary action into the porous tablet matrix. Subsequently, the polymer chains undergo substantial hydration and swelling, generating disruptive pressures of 50-250 kPa within the tablet structure. These combined actions rapidly overcome the compressive forces holding the tablet together, achieving disintegration times as low as 15-45 seconds for immediate-release formulations.

Pharmaceutical Applications of CCMC-Na

Oral Solid Dosage Forms

In immediate-release tablets, CCMC-Na is incorporated at concentrations of 2-8% w/w. The material enables rapid disintegration (typically under 60 seconds) even in hard tablets with high tensile strength. Unlike traditional disintegrants, CCMC-Na maintains efficacy across compression forces ranging from 5 kN to 30 kN, providing robust performance in high-speed tableting processes.

Orally Disintegrating Tablets (ODTs)

CCMC-Na provides critical functionality in ODT formulations, where disintegration must occur in the oral cavity within 30 seconds. At concentrations of 5-15%, it facilitates rapid dissolution without grittiness or poor mouthfeel. The material's swelling action creates porous channels throughout the tablet matrix, enabling rapid water penetration without generating excessive viscosity that would delay disintegration.

Controlled Release Systems

In floating gastroretentive systems, CCMC-Na functions both as a disintegrant and swelling agent. When formulated with gas-generating compounds, the material helps develop cohesive gel layers that extend gastric residence time from 4-8 hours. Researchers have documented increased bioavailability of drugs with narrow absorption windows when using CCMC-Na-based floating systems.

Processing Considerations

Granulation Technology

CCMC-Na demonstrates compatibility with various granulation techniques. For wet granulation processes, intragranular addition of 1-3% concentration is recommended. In dry granulation (slugging or roller compaction), the material maintains disintegration efficiency even after compacting forces up to 30 kN. Direct compression formulations benefit from CCMC-Na's excellent flow properties (angle of repose 25-30°) and compressibility index values of 15-22%.

Compression Parameters

The material exhibits low elastic recovery (4-7%) compared to other superdisintegrants, reducing tablet capping tendencies during ejection. Optimal compression parameters include precompression force at 1.5-2.5 kN and main compression between 5-20 kN for most formulations. Tablet hardness shows minimal impact on disintegration time for formulations containing CCMC-Na - studies document disintegration within 45 seconds even at hardness values up to 18 kp.

Quality Control and Regulatory Compliance

Tangzhi Technology's CCMC-Na undergoes rigorous quality control testing aligned with pharmacopeial standards. Batch certification includes testing for: Degree of Substitution (Method: USP/NF titration), cross-linking ratio (NMR spectroscopy), residual solvents (GC-MS), heavy metals (ICP-MS), microbial limits (USP <61>), and endotoxin levels (USP <85>). Documentation includes certificates of analysis with full ICH Q3D elemental impurities risk assessment.